enGene Holdings Inc.
ENGNHealthcare|Biotechnology|CA
$1.75
+0.07 (+4.17%)
DCF Value
$0.28
Tangible Book / Share
$3.30
Cash / Share
$3.82
Financials
Financial Snapshot
Market Cap
$117.3M
Enterprise Value
$109.5M
Revenue (TTM)
$0.00
Net Income (TTM)
-$4.9M
Cash & Investments
$266.3M
Net Cash
$233.0M
Free Cash Flow (TTM)
-$104.0M
Operating CF (TTM)
-$103.3M
Debt/Equity
0.14
Cash Runway & Burn Rate
Cash on Hand
$266.3M
Quarterly Burn
$25.8M
Monthly Burn
$8.6M
Est. Runway
~10.3 quarters
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Investments | — | $1.1M | $314.2K | $81.6M | $238.4M | $193.8M | $266.3M | |
| Operating Cash Flow | -$13.1M | -$16.0M | -$17.6M | -$24.7M | -$48.3M | -$99.2M | -$103.3M | |
| Free Cash Flow | -$13.3M | -$16.2M | -$17.7M | -$25.1M | -$49.2M | -$100.7M | -$104.0M | |
| Capital Expenditure | -$192.0K | -$248.0K | -$153.0K | -$318.0K | -$925.0K | -$1.5M | -$688.0K | |
| Financing Cash Flow | $12.8M | $22.5M | $28.0M | $86.1M | $265.7M | $1.5M | $143.7M |
R&D Spending
R&D (TTM)
$96.3M
R&D Intensity
—
R&D Growth vs Prior
+1.9%
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $10.6M | $12.5M | $15.5M | $16.5M | $38.3M | $94.5M | $96.3M | |
| SG&A | $3.2M | $3.2M | $3.3M | $8.5M | $24.0M | $28.7M | $42.7M |
Income Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $547.0K | |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$547.0K | |
| R&D | $10.6M | $12.5M | $15.5M | $16.5M | $38.3M | $94.5M | $96.3M | |
| SG&A | $3.2M | $3.2M | $3.3M | $8.5M | $24.0M | $28.7M | $42.7M | |
| Operating Income | -$13.9M | -$15.9M | -$19.4M | -$26.1M | -$62.3M | -$123.2M | -$4.7M | |
| Interest Expense | $3.7M | $5.0M | $1.4M | $5.0M | $2.8M | $3.0M | $3.1M | |
| Pretax Income | -$15.1M | -$23.4M | -$24.4M | -$99.9M | -$55.2M | -$117.3M | -$5.4M | |
| Net Income | -$15.1M | -$23.4M | -$24.5M | -$99.9M | -$55.1M | -$117.3M | -$4.9M | |
| EPS (Diluted) | -0.95 | -0.01 | -1.84 | -4.24 | -1.46 | -2.29 | -0.28 | |
| EBITDA | -$12.9M | -$18.1M | -$22.8M | -$94.8M | -$52.0M | -$113.8M | -$131.9M | |
| Shares Out. (M) | 15.81 | 15.81 | 15.81 | 23.56 | 44.64 | 51.12 | 69.73 |
Balance Sheet
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | — | $1.1M | $314.2K | $81.5M | $173.0M | $50.2M | $41.0M | |
| Short-Term Investments | — | $0.00 | $0.00 | $76.0K | $65.4M | $143.7M | $225.3M | |
| Total Current Assets | — | $1.6M | $511.8K | $85.4M | $247.4M | $201.4M | $277.9M | |
| Total Assets | — | $131.4M | $132.0M | $87.0M | $311.2M | $221.5M | $288.3M | |
| Total Current Liabilities | — | $327.4K | $893.5K | $5.3M | $14.7M | $32.0M | $27.2M | |
| Long-Term Debt | — | $0.00 | $0.00 | $9.2M | $22.5M | $15.3M | $25.2M | |
| Total Liabilities | — | $4.1M | $4.6M | $14.5M | $38.6M | $53.8M | $58.0M | |
| Stockholders' Equity | — | $127.4M | $127.4M | $72.5M | $272.6M | $167.7M | $230.3M | |
| Retained Earnings | — | -$2.3M | -$4.1M | -$199.6M | -$254.7M | -$372.0M | -$464.5M |
Cash Flow Statement
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$13.1M | -$16.0M | -$17.6M | -$24.7M | -$48.3M | -$99.2M | -$103.3M | |
| Capital Expenditure | -$192.0K | -$248.0K | -$153.0K | -$318.0K | -$925.0K | -$1.5M | -$688.0K | |
| Free Cash Flow | -$13.3M | -$16.2M | -$17.7M | -$25.1M | -$49.2M | -$100.7M | -$104.0M | |
| Investing Cash Flow | -$192.0K | -$247.0K | -$153.0K | -$318.0K | -$126.0M | -$25.1M | -$32.0M | |
| Financing Cash Flow | $12.8M | $22.5M | $28.0M | $86.1M | $265.7M | $1.5M | $143.7M | |
| Issuance of Stock | $0.00 | $14.0K | $12.0K | $56.9M | $260.1M | $2.2M | $142.3M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $13.0M | $7.1M | $28.4M | $33.3M | $13.1M | -$699.0K | $1.4M | |
| Stock Based Comp. | $150.0K | $435.0K | $116.0K | $3.5M | $5.3M | $9.6M | $17.4M | |
| Net Change in Cash | -$456.0K | $6.4M | $9.4M | $61.1M | $91.5M | -$122.9M | $8.4M |
Dilution Tracker
Shares outstanding grew 223.3% over 5 years — significant dilution
Shares Outstanding
67M
5-Year Share Growth
+223.3%
Stock Issuance (TTM)
$142.3M
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 15.81 | 15.81 | 15.81 | 23.56 | 44.64 | 51.12 | 69.73 | |
| Change vs Prior % | — | 0.0% | 0.0% | 49.0% | 89.5% | 14.5% | 36.4% | |
| Stock Issuance | $0.00 | $14.0K | $12.0K | $56.9M | $260.1M | $2.2M | $142.3M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $150.0K | $435.0K | $116.0K | $3.5M | $5.3M | $9.6M | $17.4M |
Margins & Profitability
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| ROE % | 0.0% | -18.4% | -19.2% | -137.8% | -20.2% | -69.9% | -2.1% | |
| ROA % | 0.0% | -17.8% | -18.5% | -114.9% | -17.7% | -53.0% | -1.7% | |
| ROIC % | 0.0% | -12.0% | -14.7% | -31.7% | -20.9% | -61.7% | -1.6% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Income | 0.0% | -14.6% | -22.4% | -34.1% | -139.1% | -97.7% | |
| Net Income | 0.0% | -55.6% | -4.4% | -308.5% | 44.8% | -112.7% | |
| EPS (Diluted) | 0.0% | 98.5% | -12767.1% | -130.4% | 65.6% | -56.8% | |
| Operating Cash Flow | 0.0% | -22.4% | -10.1% | -40.6% | -95.1% | -105.5% | |
| Free Cash Flow | 0.0% | -22.5% | -9.3% | -41.2% | -96.3% | -104.7% | |
| R&D Expense | 0.0% | 17.4% | 24.1% | 6.4% | 132.8% | 146.6% | |
| SG&A Expense | 0.0% | -2.6% | 3.3% | 159.8% | 183.1% | 19.6% | |
| Total Assets | 0.0% | 0.0% | 0.5% | -34.1% | 257.8% | -28.8% | |
| Book Value / Share | 0.0% | 0.0% | 0.0% | -61.8% | 98.5% | -46.3% | |
| Debt | 0.0% | 0.0% | 672.6% | -69.5% | 155.9% | 27.1% | |
| Diluted Shares | 0.0% | 0.0% | 0.0% | 49.0% | 89.5% | 14.5% |
Valuation
P/E (TTM)At Loss
P/S0.00
P/B0.53
10Y Low / Med / High1.45 / 2.48 / 6.50
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.28
Tangible Book / Share
$3.30
Net Current Assets / Share
$3.28
Graham Net-Net
$3.02
Cash / Share
$3.82
| Metric | Trend | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -21.05 | -1398.60 | -10.87 | -4.72 | -6.06 | -3.15 | -6.25 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | 0.00 | 2.48 | 2.48 | 6.50 | 1.45 | 2.20 | 0.53 | |
| EV/EBITDA | 0.00 | -17.60 | -15.28 | -4.21 | -4.75 | -3.08 | -0.83 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-1.52
Distress
Piotroski F-Score
0
Weak
Forward Estimates (consensus)
| Metric | FY2027 | FY2028 | FY2029 |
|---|---|---|---|
| Revenue | $5.8M | $39.3M | $99.1M |
| Net Income | -$76.6M | -$51.6M | -$24.0M |
| EPS | $-1.50 | $-1.01 | $-0.47 |
| # Analysts (EPS) | 5 | 2 | 1 |
Dividends
Frequency
Quarterly
Recent Payments
| Ex-Date | Pay Date | Amount | Frequency |
|---|---|---|---|
| Feb 2, 2015 | $0.13 | Quarterly | |
| Dec 1, 2014 | Dec 5, 2014 | $0.14 | Monthly |
| Nov 3, 2014 | Nov 7, 2014 | $0.15 | Monthly |
| Oct 1, 2014 | Oct 7, 2014 | $0.15 | Semi-Annual |
| May 1, 2014 | $0.13 | Semi-Annual | |
| Dec 2, 2013 | Dec 6, 2013 | $0.12 | Monthly |
| Nov 1, 2013 | Nov 7, 2013 | $0.12 | Monthly |
| Oct 1, 2013 | Oct 7, 2013 | $0.12 | Quarterly |
| Aug 1, 2013 | $0.12 | Quarterly | |
| May 1, 2013 | $0.12 | Special | |
| Dec 26, 2012 | $0.11 | Monthly | |
| Dec 3, 2012 | Dec 7, 2012 | $0.11 | Monthly |
| Nov 1, 2012 | Nov 7, 2012 | $0.12 | Monthly |
| Oct 1, 2012 | Oct 5, 2012 | $0.12 | Monthly |
| Sep 4, 2012 | Sep 10, 2012 | $0.12 | Monthly |
| Aug 1, 2012 | Aug 7, 2012 | $0.12 | Monthly |
| Jul 2, 2012 | Jul 9, 2012 | $0.11 | Monthly |
| Jun 1, 2012 | Jun 7, 2012 | $0.11 | Monthly |
| May 1, 2012 | May 7, 2012 | $0.12 | Monthly |
| Apr 2, 2012 | Apr 9, 2012 | $0.18 | Monthly |